Recruiting Liver Cancer Studies in Hong Kong
About Liver Cancer Clinical Trials in Hong Kong
Liver cancer most commonly presents as hepatocellular carcinoma (HCC) and is often associated with chronic liver disease or hepatitis. It is one of the fastest-growing causes of cancer death. Treatment options include surgery, liver transplant, ablation, and systemic therapies.
There are currently 1 liver cancer clinical trials recruiting participants in Hong Kong, HONG%20KONG. These studies are seeking a combined 46 participants. Research is being sponsored by SCG Cell Therapy Pte. Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Liver Cancer Clinical Trials in Hong Kong — FAQ
Are there liver cancer clinical trials in Hong Kong?
Yes, there are 1 liver cancer clinical trials currently recruiting in Hong Kong, HONG%20KONG. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hong Kong?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hong Kong research site will contact you about next steps.
Are clinical trials in Hong Kong free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hong Kong studies also compensate for your time and travel.
What liver cancer treatments are being tested?
The 1 active trials in Hong Kong are testing new therapies including novel drugs, biologics, and treatment approaches for liver cancer.
Data updated March 2, 2026 from ClinicalTrials.gov